RBL001/RBL002
RB_0001-01
Phase 1 mab completed
Quick answer
RBL001/RBL002 for Melanoma is a Phase 1 program (mab) at Atrium Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Atrium Therapeutics
- Indication
- Melanoma
- Phase
- Phase 1
- Modality
- mab
- Status
- completed